DK0723552T3 - Oligopeptider afledt af fragmenter af C-reaktivt protein - Google Patents

Oligopeptider afledt af fragmenter af C-reaktivt protein

Info

Publication number
DK0723552T3
DK0723552T3 DK94916966T DK94916966T DK0723552T3 DK 0723552 T3 DK0723552 T3 DK 0723552T3 DK 94916966 T DK94916966 T DK 94916966T DK 94916966 T DK94916966 T DK 94916966T DK 0723552 T3 DK0723552 T3 DK 0723552T3
Authority
DK
Denmark
Prior art keywords
fragments
pct
reactive protein
oligopeptides derived
derived
Prior art date
Application number
DK94916966T
Other languages
Danish (da)
English (en)
Inventor
Massimo Pinori
Patrizia Caretto
Flavio Leoni
Fabrizio Marcucci
Gianni Gromo
Paolo Mascagni
Silvana Cappelletti
Original Assignee
Italfarmaco Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Italfarmaco Spa filed Critical Italfarmaco Spa
Application granted granted Critical
Publication of DK0723552T3 publication Critical patent/DK0723552T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4737—C-reactive protein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK94916966T 1993-10-12 1994-05-16 Oligopeptider afledt af fragmenter af C-reaktivt protein DK0723552T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI932154A IT1271486B (it) 1993-10-12 1993-10-12 Oligopeptidi immunomodulatori derivati di frammenti della proteina c- reattiva
PCT/EP1994/001574 WO1995010531A1 (en) 1993-10-12 1994-05-16 Oligopeptides derived from c-reactive protein fragments

Publications (1)

Publication Number Publication Date
DK0723552T3 true DK0723552T3 (da) 2003-02-24

Family

ID=11367010

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94916966T DK0723552T3 (da) 1993-10-12 1994-05-16 Oligopeptider afledt af fragmenter af C-reaktivt protein

Country Status (19)

Country Link
US (1) US6057295A (no)
EP (1) EP0723552B1 (no)
JP (1) JP3221881B2 (no)
KR (1) KR100363408B1 (no)
CN (1) CN1041524C (no)
AT (1) ATE226591T1 (no)
AU (1) AU684511B2 (no)
CA (1) CA2173939C (no)
DE (1) DE69431603T2 (no)
DK (1) DK0723552T3 (no)
ES (1) ES2185652T3 (no)
FI (1) FI961584A0 (no)
HU (1) HUT75538A (no)
IL (1) IL109761A0 (no)
IT (1) IT1271486B (no)
NO (1) NO961423L (no)
PT (1) PT723552E (no)
WO (1) WO1995010531A1 (no)
ZA (1) ZA943610B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6342481B1 (en) * 1993-10-12 2002-01-29 Italfarmaco S.P.A. Oligopeptides derived from C-reactive protein fragments
EP1408031A1 (en) * 2002-10-09 2004-04-14 3 D Gene Pharma Pyrolidine derivatives useful in treatment of hepatitis C virus infection
US8680263B2 (en) 2008-09-19 2014-03-25 Nektar Therapeutics Carbohydrate-based drug delivery polymers and conjugates thereof
CA2787376A1 (en) 2010-01-19 2011-07-28 President And Fellows Of Harvard College Engineered opsonin for pathogen detection and treatment
SG10201608671SA (en) 2011-07-18 2016-12-29 Harvard College Engineered Microbe-Targeting Molecules and Uses Thereof
US10551379B2 (en) 2013-03-15 2020-02-04 President And Fellows Of Harvard College Methods and compositions for improving detection and/or capture of a target entity
AU2014268603B2 (en) 2013-05-21 2018-03-22 President And Fellows Of Harvard College Engineered heme-binding compositions and uses thereof
EP3546474B1 (en) 2013-12-18 2021-07-07 President and Fellows of Harvard College Crp capture/detection of gram positive bacteria
US10435457B2 (en) 2015-08-06 2019-10-08 President And Fellows Of Harvard College Microbe-binding molecules and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2945239A1 (de) * 1979-11-09 1981-05-21 Troponwerke GmbH & Co KG, 5000 Köln Oligopeptide, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
US4353823A (en) * 1981-09-01 1982-10-12 Chipens Gunar I Synthetic analog of tuftisin
GB8525615D0 (en) * 1985-10-17 1985-11-20 Hoffmann La Roche Polypeptides
DE3783280T2 (de) * 1986-07-16 1993-05-06 Eniricerche Spa Teilweise retro-invertierte analoge des tuftsin, methode zu ihrer herstellung und pharmazeutische zusammensetzungen, die sie enthalten.
IT1254883B (it) * 1992-04-16 1995-10-11 Italfarmaco Spa Tetrapeptidi parzialmente modificati e retroinvertiti, analoghi di frammenti della proteina c-reattiva.

Also Published As

Publication number Publication date
JP3221881B2 (ja) 2001-10-22
HUT75538A (en) 1997-05-28
CN1041524C (zh) 1999-01-06
ES2185652T3 (es) 2003-05-01
IT1271486B (it) 1997-05-28
FI961584A (fi) 1996-04-11
CN1133048A (zh) 1996-10-09
DE69431603D1 (de) 2002-11-28
DE69431603T2 (de) 2003-03-13
CA2173939A1 (en) 1995-04-20
CA2173939C (en) 2002-08-27
NO961423L (no) 1996-06-10
AU6844194A (en) 1995-05-04
EP0723552B1 (en) 2002-10-23
KR100363408B1 (ko) 2003-02-11
ATE226591T1 (de) 2002-11-15
ITMI932154A1 (it) 1995-04-12
NO961423D0 (no) 1996-04-11
AU684511B2 (en) 1997-12-18
IL109761A0 (en) 1994-08-26
ITMI932154A0 (it) 1993-10-12
HU9600934D0 (en) 1996-08-28
US6057295A (en) 2000-05-02
EP0723552A1 (en) 1996-07-31
PT723552E (pt) 2003-02-28
JPH09503200A (ja) 1997-03-31
FI961584A0 (fi) 1996-04-11
WO1995010531A1 (en) 1995-04-20
ZA943610B (en) 1995-01-25

Similar Documents

Publication Publication Date Title
CY1119263T1 (el) Συνθεσεις και μεθοδοι για την αυξηση της ασβεστοποιησεως των οστων
DK0914144T3 (da) Terapeutiske anvendelser af BPI-protein-produkter til human meningokokæmi
BR0112111A (pt) Realce de respostas imunes mediadas por proteìna de fusão de anticorpo-citocina por tratamento combinado com agentes de realce de captação de imunocitocina
DK0733109T3 (da) BMP-12, BMP-13 og seneinducerende præparater dermed
DK1068241T3 (da) Antistofvarianter og fragmenter deraf
DK0793674T3 (da) Inhibitorer af human neutrofil elastase
PT695758E (pt) Amidas e esteres de pentapeptidos inibidores de cancro humano
WO1998033509A3 (en) Useful properties of human lactoferrin and variants thereof
BG104149A (en) Interleukin-18-binding proteins, methods for their preparation and administration
CY1108610T1 (el) Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες
DK0960127T3 (da) Isoleret dimert fibroblastaktiverende protein-alfa og anvendelser deraf
UA27035C2 (uk) Кристал білка, зшитого багатофуhкціоhальhим зшивальним агеhтом (варіаhти), пристрій, що містить кристал білка та спосіб отримаhhя аспартаму
ATE234111T1 (de) Therapeutische verwendungen von bpi-protein produkten bei menschen mit durch trauma verursachter blutung
DK0723552T3 (da) Oligopeptider afledt af fragmenter af C-reaktivt protein
IL145689A0 (en) Methods
ES2088128T3 (es) Aminosulfonilureas inhibidoras de acat.
WO2003027251A3 (en) Novel molecules of the pyrin domain protein family and uses thereof
ATE316136T1 (de) Nierenpolycystose-gen
DE69839943D1 (de) Verhinderung von immunreaktivität durch verarmung oder inhibition von antigen-präsentierenden zellen
EA200001127A1 (ru) Бактериальные феромоны и их использование
FI961339A (fi) Triaryylieteenijohdannaiset käytettäväksi hoidossa
CO4920227A1 (es) Histidina-n-bencil glicinamida sustituida con cicloalquilos .
BR0108187A (pt) Moléculas trade e usos relacionados com as mesmas
LT2001045A (en) Compositions and use thereof for downmodulating the immune response to therapeutic proteins
DK0952982T3 (da) Hidtil ukendte hepatitis B inhibitorer